Please use this identifier to cite or link to this item:
|Title:||Genetic characterisation of a whiB7 mutant of a Mycobacterium tuberculosis clinical strain|
Thailand National Center for Genetic Engineering and Biotechnology
King Mongkut's Institute of Technology Ladkrabang
|Keywords:||Immunology and Microbiology;Medicine|
|Citation:||Journal of Global Antimicrobial Resistance. Vol.3, No.4 (2015), 262-266|
|Abstract:||© 2015 International Society for Chemotherapy of Infection and Cancer. Mycobacterium tuberculosis is naturally resistant to clarithromycin (CLR). The genes Rv3197A (whiB7) and Rv1988 (ermMT) have been shown to be involved in the resistant phenotype. In this study, a CLR-susceptible M. tuberculosis clinical strain was identified, designated as DS3214, and the nucleotide sequences and expression profiles of whiB7 and ermMT were investigated. The results revealed that strain DS3214 contained a one nucleotide deletion in whiB7, leading to a truncated peptide. Expression of whiB7 was low, whereas comparable expression of ermMT was determined compared with the reference strain M. tuberculosis H37Rv. Overexpression of the mutant whiB7 in M. tuberculosis H37Ra did not increase the minimum inhibitory concentration (MIC) to CLR or kanamycin, indicating the defect of the mutant WhiB7. The CLR-susceptible M. tuberculosis clinical strain, whose whiB7 is naturally mutated, was first described in this study and whiB7 has been shown to play a role in the CLR-susceptible phenotype.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.